Synapse - Works

Results (13087)

The impact of metastatic sites on checkpoint inhibitor outcomes in patients with cutaneous and unknown primary melanoma

Meeting Abstract

Krieger, P.; Sanchez-Vega, F.; Schultz, N.; Shoushtari, A.
Journal for ImmunoTherapy of Cancer (2019)

Fulltext@MSK | Save

T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers

Meeting Abstract

Ma, J.; Klatt, M.; Dundar, F.; Zumbo, P.; Femia, M.; Betel, D.; Scheinberg, D.; Baker, B.; Klebanoff, C.; Chandran, S.
Journal for ImmunoTherapy of Cancer (2019)

Fulltext@MSK | Save

First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: Primary analysis after ≥ 15 months of follow-up from JAVELIN Merkel 200, a registrational phase 2 trial

Meeting Abstract

D'Angelo, S.; Lebbé, C.; Mortier, L.; Brohl, A.; Fazio, N.; Grob, J. J.; Prinzi, N.; Hanna, G.; Hassel, J.; Kiecker, F.; more...
Journal for ImmunoTherapy of Cancer (2019)

Fulltext@MSK | Save

Phase 1 trial of NY-ESO-1-specific adoptive T-cell therapy with GSK3377794 in patients with advanced synovial sarcoma

Meeting Abstract

D'Angelo, S.; Demetri, G.; Van Tine, B.; Druta, M.; Glod, J.; Chow, W.; Tress, J.; DeYoung, M. P.; Hasan, A.; Wu, Y.; more...
Journal for ImmunoTherapy of Cancer (2019)

Fulltext@MSK | Save

Autologous T cells with NY-ESO-1-specific T-cell receptor (GSK3377794) in HLA-A*02+ previously-treated and -untreated advanced metastatic/unresectable synovial sarcoma: A master protocol study design

Meeting Abstract

D'Angelo, S.; Blay, J. Y.; Chow, W.; Demetri, G.; Thistlethwaite, F.; Wagner, M.; Loeb, D.; Attia, S.; Razak, A.; Haanen, J.; more...
Journal for ImmunoTherapy of Cancer (2019)

Fulltext@MSK | Save

Feasibility of an outpatient 12-step desensitization for patients with history of carboplatin hypersensitivity reactions (HSR) undergoing retreatment with carboplatin for recurrent ovarian or endometrial cancer

Meeting Abstract

LaVigne, K.; Eroglu, I.; Mainardi, T.; Sabbatini, P.; Sklarin, N.; O'Cearbhaill, R.
International Journal of Gynecological Cancer (2019)

Fulltext@MSK | Save

Ovarian cancer care delivery: Diversity in public perception and access to care

Meeting Abstract

Cowan, R.; Esposito-Amery, P.; Seier, K.; Iasonos, A.; O'Cearbhaill, R.; Tew, W.; Jewell, E.; Brown, C.; Zivanovic, O.; Sonoda, Y.; more...
International Journal of Gynecological Cancer (2019)

Fulltext@MSK | Save

Identification of neoantigens from non-primary tumor tissue in patients with recurrent ovarian cancer by sequencing and subsequent HLA ligand mass spectrometry

Meeting Abstract

O'Cearbhaill, R.; Klatt, M.; Mun, S. S.; Korontsvit, T.; Socci, N.; Guzman, S.; Mattar, M.; Zivanovic, O.; Dao, T.
International Journal of Gynecological Cancer (2019)

Fulltext@MSK | Save

Phase II study of enzalutamide in androgen receptor positive (AR+) recurrent ovarian cancer: Final results

Meeting Abstract

Grisham, R.; Giri, D.; Henson, M.; Iasonos, A.; Zhou, Q.; McDonnell, A.; Girshman, J.; O'Cearbhaill, R.; Zamarin, D.; Aghajanian, C.
International Journal of Gynecological Cancer (2019)

Fulltext@MSK | Save

In vivo study (MYCEC0617) of CD34+-HSC and CEC mutational profile for investigating cell origin and pathogenesis of primary myelofibrosis (PMF)

Meeting Abstract

Farina, M.; Bernardi, S.; D'Adda, M.; Foroni, C.; Zanaglio, C.; Dunbar, A.; Re, F.; Cattina, F.; Rambaldi, B.; Zollner, T.; more...
Haematologica (2019)

Fulltext@MSK | Save